Long-term Disease Control After Probable Endobronchial Small-cell Transformation During Osimertinib Therapy for <i>EGFR</i> -mutant Lung Adenocarcinoma

NOZOMU MURAYAMA, MINEHIKO INOMATA, MASAHIRO MATSUMOTO, DAISUKE FURUKAWA, TOMOMI ICHIKAWA, YOSHINOBU MAEDA, HIDEKI SHINNO, YUKO NAKANISHI, SHIN ISHIZAWA

Open source

DOI: 10.21873/invivo.14531
Published: 2026-10-29
Container: In Vivo
Publisher: International Institute of Anticancer Research
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21873/invivo.14531,
  title = {Long-term Disease Control After Probable Endobronchial Small-cell Transformation During Osimertinib Therapy for
                    <i>EGFR</i>
                    -mutant Lung Adenocarcinoma},
  author = {NOZOMU MURAYAMA and MINEHIKO INOMATA and MASAHIRO MATSUMOTO and DAISUKE FURUKAWA and TOMOMI ICHIKAWA and YOSHINOBU MAEDA and HIDEKI SHINNO and YUKO NAKANISHI and SHIN ISHIZAWA},
  year = {2026},
  journal = {In Vivo},
  doi = {10.21873/invivo.14531},
  url = {https://doi.org/10.21873/invivo.14531}
}

RIS

TY  - JOUR
TI  - Long-term Disease Control After Probable Endobronchial Small-cell Transformation During Osimertinib Therapy for
                    <i>EGFR</i>
                    -mutant Lung Adenocarcinoma
AU  - NOZOMU MURAYAMA
AU  - MINEHIKO INOMATA
AU  - MASAHIRO MATSUMOTO
AU  - DAISUKE FURUKAWA
AU  - TOMOMI ICHIKAWA
AU  - YOSHINOBU MAEDA
AU  - HIDEKI SHINNO
AU  - YUKO NAKANISHI
AU  - SHIN ISHIZAWA
PY  - 2026
JO  - In Vivo
DO  - 10.21873/invivo.14531
UR  - https://doi.org/10.21873/invivo.14531
ER  -

APA

MURAYAMA, N., INOMATA, M., MATSUMOTO, M., FURUKAWA, D., ICHIKAWA, T., MAEDA, Y., SHINNO, H., NAKANISHI, Y., & ISHIZAWA, S. (2026). Long-term Disease Control After Probable Endobronchial Small-cell Transformation During Osimertinib Therapy for <i>EGFR</i> -mutant Lung Adenocarcinoma. In Vivo. https://doi.org/10.21873/invivo.14531

Source records

crossref · retrieved 2026-11-04T23:34:25.203Z